This fact sheet reviews common sites of cancer metastasis, methods of spread, treatment, and additional details.
A trial comparing pazopanib and sunitinib found pazopanib to have better safety and health-related quality-of-life profiles among persons with metastatic renal cell carcinoma.
Although pazopanib and sunitinib are similarly effective in patients with metastatic renal-cell cancer, pazopanib is associated with better safety and quality of life, according to a study.
Surgery is often the first step in treating kidney cancer, and new data questions whether removing only the tumor is better than removing the entire kidney.
Using robotic ultrasound probes for identification of kidney tumors during robotic partial nephrectomy offered the advantage of surgeon autonomy compared with the use of laparoscopic ultrasound probes.
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|